**5.3.3 Amantadine (1-adamantylamine, 1-aminoadamantane)**

Amantadine shows a weak NMDA receptor antagonism and anti-cholinergic effects. In a cross-over study with guanidine, no benefits for ALS patients have been described (Munsat et al., 1981).
